Why Are UnitedHealth Group and Bristol-Myers Squibb Attracting Hedge Funds

Related Articles

Why Are Barclays Analysts Bullish on Eli Lilly and Bristol-Myers Squibb

7 months ago

Why is Barclays Bullish on Bristol-Myers Squibb (BMY) Now

7 months ago

Is Bristol Myers Squibb's New Multiple Myeloma Drug a Game Changer

7 months ago

Is Bristol Myers Squibb's Deucravacitinib a Game-Changer for SLE Patients and BMY Investors

5 months ago

Category

You may also like

Stock News•3 weeks ago

Wall Street's Bull Case for Bristol Myers Squibb Is Getting Louder

Bristol Myers Squibb shares have risen over 17% year-to-date, with speculation that AstraZeneca could acquire the company driving the bull case.

BMY

Share

Stock News•1 months ago

A Leading Hedge Fund Just Placed Massive Bets on Broadcom and Intel Stocks. Should You Follow Suit?

A leading hedge fund placed massive bets on Broadcom and Intel stocks, two chipmakers with very different 2026 performances. The moves signal divergent outlooks, but no specific figures or timing were...

AVGO

Share

Stock News•2 months ago

UnitedHealth Pulls Back Post 52-Week High: Healthcare ETFs to Watch

UnitedHealth pulled back from a 52-week high after earnings, as stronger guidance offset Medicaid headwinds, spotlighting healthcare ETFs with sizable exposure.

UNH

Share